Both in Biotechnology
Inhibikase Therapeutics vs Artiva Biotherapeutics
Over the past year IKT returned 0.0% and ARTV returned +11.0%; their daily moves had a correlation of 0.23.
IKT 0.0% ARTV +11.0%Growth of $1, one year, split-adjusted
| Metric | IKT | ARTV |
|---|---|---|
| Price | $1.48 | $4.20 |
| Market cap | $206.5M | $205.3M |
| Today | −3.90% | +0.24% |
| 1 month | −26.0% | −41.1% |
| 6 months | −23.3% | −60.4% |
| Year to date | −27.8% | −2.1% |
| 1 year | +0.7% | +0.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $159.0M | $349.4M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 93.3% |
| Short % of float | 17.8% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).